Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 1403Terminated 349Unknown 273Recruiting 230Active not recruiting 144Withdrawn 114Not yet recruiting 45Suspended 8Enrolling by invitation 3

Sponsor Class

OTHER 3

Study Type

Observational 4Interventional 3

Sponsor

Cancer Type

Lymphoid 3Thoracic 1Sarcoma 1NET 1Endocrine 1Breast 1

Conditions

Neoplasms 40Breast Neoplasms 40Prostatic Neoplasms 24Colorectal Neoplasms 24Uterine Cervical Neoplasms 16Carcinoma, Non-Small-Cell Lung 14Anxiety Disorders 13Stomach Neoplasms 9Lymphoma, Follicular 9Lung Neoplasms 9Leukemia, Myeloid, Acute 9Carcinoma, Hepatocellular 8Brain Neoplasms 8Urinary Bladder Neoplasms 7Sarcoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 7Ovarian Neoplasms 6Epilepsy 6Depression 6Colonic Neoplasms 6Uterine Cervical Dysplasia 5Small Cell Lung Carcinoma 5Pain 5Glioma 5Dementia 5Cholangiocarcinoma 5Recurrence 4

Interventions

Fluorodeoxyglucose F18 1Biopsy, Fine-Needle 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Lymphoma × Clear all
NCT06645093 2026-03-10

FasteStudien

University of Oslo

Phase NA Enrolling by invitation
40 enrolled
Lymphoid

Intermittent Fasting, Fasting, Lymphoma, Neoplasms

NCT06848738 2025-02-27

IMPROVED

Zealand University Hospital

Phase NA Enrolling by invitation
362 enrolled
LymphoidThoracic

Lung Neoplasms, Lymphoma, Sarcoidosis

NCT05396118 2024-05-14

Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients

Rigshospitalet, Denmark

Phase 2 Enrolling by invitation
15 enrolled
BreastEndocrineLymphoidNETSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡